Mantle cell lymphoma: open trials in Sweden

• NCT06084936

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Skånes University Hospital, Skånes Department of Onclology, Lund · Akademiska sjukhuset, Onkologkliniken, Uppsala

  Registry updated 2026-11-05

• NCT05006716

  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  Trial Treatment · Phase 1/2 · BeOne Medicines

  Sahlgrenska University Hospital Hematology, Gothenburg · Karolinska Universitetssjukhuset Solna, Stockholm

  Registry updated 2026-10-05

• 2024-512922-27-00

  PIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA

  Trial Treatment · Phase 2 · Klinikum der Universitaet Muenchen AöR

  Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Region Vaesterbotten, Umea · Uppsala University Hospital, Uppsala

  Registry updated 2026-09-30

• 2023-503206-37-00

  A Study to Compare the Efficacy and Safety of Glofitamab as a Single Agent Versus Investigator’s Choice in Patients with Relapsed/Refractory Mantle Cell Lymphoma

  Trial Treatment · Phase 3 · F. Hoffmann-La Roche AG

  Region Skane Skanes Universitetssjukhus, Lund · Uppsala University Hospital, Uppsala

  Registry updated 2026-09-09

• NCT06002659

  CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)

  Trial Treatment · Phase 1/2 · Uppsala University

  Karolinska University Hospital, Huddinge · Uppsala University Hospital, Uppsala

  Registry updated 2024-05-09

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error